
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.25 | 1.25 | 0.00 |
Shares | 98.75 | 98.75 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.17 | 15.68 |
Price to Book | 2.69 | 2.49 |
Price to Sales | 2.09 | 1.70 |
Price to Cash Flow | 11.98 | 10.55 |
Dividend Yield | 2.17 | 2.51 |
5 Years Earnings Growth | 8.66 | 9.61 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 21.75 | 21.22 |
Healthcare | 17.94 | 15.67 |
Industrials | 17.30 | 11.66 |
Technology | 11.96 | 12.37 |
Consumer Cyclical | 8.75 | 6.72 |
Communication Services | 7.50 | 5.53 |
Energy | 6.71 | 7.74 |
Real Estate | 3.20 | 3.49 |
Basic Materials | 3.16 | 3.41 |
Consumer Defensive | 1.73 | 8.51 |
Number of long holdings: 51
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
JPMorgan | US46625H1005 | 4.80 | 267.56 | +0.03% | |
Goldman Sachs | US38141G1040 | 3.89 | 619.03 | +0.51% | |
Fiserv | US3377381088 | 3.58 | 166.66 | +4.73% | |
Parker-Hannifin | US7010941042 | 3.49 | 680.40 | +1.15% | |
Honeywell | US4385161066 | 3.40 | 222.88 | +0.27% | |
Meta Platforms | US30303M1027 | 3.21 | 640.34 | -0.55% | |
AbbVie | US00287Y1091 | 3.18 | 184.02 | +1.29% | |
Boston Scientific | US1011371077 | 2.74 | 106.04 | +1.13% | |
Abbott Labs | US0028241000 | 2.61 | 134.80 | +1.09% | |
Microsoft | US5949181045 | 2.49 | 454.27 | +0.25% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Homestead Growth | 395.94M | -6.12 | 16.37 | 14.39 | ||
Homestead Stock Index | 265.92M | -5.04 | 11.66 | 11.74 | ||
Homestead Small Company Stock | 213.2M | -4.93 | 2.26 | 5.07 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review